After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
NewAmsterdam Pharma Company NV is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of NewAmsterdam Pharma Company NV is $2.23B. A total of 0.84 million shares were traded on the day, compared to an average of 883.03K shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, NAMS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Douglas F Kling bought 500,000 shares of NAMS for 23.20 per share on Jan 27 ’25. In a previous transaction on Jan 27 ’25, Mayur Somalya bought 200,000 shares at 23.20 per share.
Among the insiders who bought shares, NAP PoolCo B.V. acquired of 1,396,241 shares on Jan 10 ’25 at a per-share price of $25.31. In another insider transaction, ForGrowth NAP B.V. sold 29,846 shares at $25.54 per share on Dec 30 ’24. Company shares held by the 10% Owner now total 10,656,172.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for NAMS in the last 3 months, the mean price target is $44.33 with high estimates of $52.00 and low estimates of $37.00. In terms of 52-week highs and lows, NAMS has a high of $27.29 and a low of $15.19.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NAMS’s latest balance sheet shows that the firm has $60.11M in Cash & Short Term Investments as of fiscal 2021. There were $185.68k in debt and $11.19M in liabilities at the time. Its Book Value Per Share was $7.01, while its Total Shareholder’s Equity was $56.37M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NAMS is Buy with a score of 4.80.
